Anatomical Therapeutic Chemical • A10BK • Sodium-glucose co-transporter 2 (SGLT2) inhibitors

A Alimentary tract and metabolism

A01 Stomatological preparations

A02 Drugs for acid related disorders

A03 Drugs for functional gastrointestinal disorders

A04 Antiemetics and antinauseants

A05 Bile and liver therapy

A06 Drugs for constipation

A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents

A08 Antiobesity preparations, excluding diet products

A09 Digestives, incl. enzymes

A10 Drugs used in diabetes

A10A Insulins and analogues

A10B Blood glucose lowering drugs, excl. insulins

A10BA Biguanides

A10BB Sulfonylureas

A10BC Sulfonamides (heterocyclic)

A10BD Combinations of oral blood glucose lowering drugs

A10BF Alpha glucosidase inhibitors

A10BG Thiazolidinediones

A10BH Dipeptidyl peptidase 4 (DDP-4) inhibitors

A10BJ Glucagon-like peptide-1 (GLP-1) analogues

A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors

A10BK01 dapagliflozin Indicated for: type 2 diabetes; heart failure; chronic kidney disease

A10BK03 empagliflozin Indicated for: type 2 diabetes mellitus; heart failure; chronic kidney disease

A10BK04 ertugliflozin Indicated for: type 2 diabetes mellitus

A10BX Other blood glucose lowering drugs, excl. insulins

A10X Other drugs used in diabetes

A11 Vitamins

A12 Mineral supplements

A13 Tonics

A14 Anabolic agents for systemic use

A15 Appetite stimulants

A16 Other alimentary tract and metabolism products